Rx USA counterclaimed for breach of contract, maintaining that Amerisource had overcharged the company and failed to honor various discounts promised by a sales representative.
The antitrust claims were dismissed at the summary judgment stage, and the contract and tort claims that proceeded to trial were all decided in favor of Amerisource.